| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |